Germany plans to offer adolescents COVID-19 vaccine from June 7 | Inquirer News

Germany plans to offer adolescents COVID-19 vaccine from June 7

/ 02:04 AM May 28, 2021

Germany plans to offer adolescents COVID-19 vaccine from June 7

FILE PHOTO: Pediatrician Anila Sternberg vaccinates a teenage girl with a dose of the Pfizer-BioNtech COVID-19 vaccine in her practice, as the spread of the new coronavirus disease (COVID-19) continues, in Bonn, Germany, May 21, 2021. REUTERS/Leon Kuegeler

BERLIN — Germany plans to make enough COVID-19 vaccine doses available to offer the first shot to children aged 12-16 from June 7, Chancellor Angela Merkel said on Thursday.

After a sluggish start to its vaccination rollout, Germany has increased the pace of inoculations and imposed nationwide lockdown measures which are now being lifted.

Article continues after this advertisement

With more than 40% of the population of around 83 million having received at least one dose, attention has turned to the question of extending vaccinations to adolescents.

FEATURED STORIES

“Every citizen will be offered a vaccination by the end of the summer. This also includes those who are now likely to be included in this vaccination offer, namely 12- to 16-year-old children,” Merkel told a news conference.

“Children and adolescents can then apply for a vaccination appointment after the end of the prioritization, knowing that the prioritization will generally be lifted on June 7,” she said after meeting regional leaders for a ‘vaccination summit’.

Article continues after this advertisement

There are 4.1 million school children in Germany aged 12 years and over, Federal Statistics Office figures show. Opinion on vaccinating them against COVID-19 is divided and the main expert panel on vaccinations has expressed caution.

Article continues after this advertisement

Some scientists say that, due to a lack of data on long-term effects, it might be better to vaccinate only adolescents with risk factors.

Article continues after this advertisement

Merkel said parents should not feel pushed into vaccinating their children.

“The important message to all parents is: school does not depend on the question of being vaccinated,” she said. “There should be no indirect coercion for parents. We have no obligation to vaccinate.”

Article continues after this advertisement

“This impression must not arise, nor the impression ‘I can only go on vacation if I have a vaccinated child’. That would be completely wrong,” she added.

The European Medicines Agency could endorse the Pfizer/BioNTech vaccine for children aged 12 to 15 on Friday.

A document made available before Thursday’s talks said Germany expects to vaccinate about 60% of people in that age group. About 3.18 million doses for each of the first and second vaccination would be needed.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

The Robert Koch Institute for infectious diseases reported a 6,313 rise in coronavirus cases in Germany on Thursday, taking the total to more than 3.66 million. The seven-day incidence fell to 41 per 100,000 people, down from around 160 a month ago. The death toll is 87,995 people.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Germany, Pfizer, teens, vaccine

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.